The efficacy and safety of remimazolam tosilate compared with propofol for endoscopic retrograde cholangiopancreatography under monitored anesthesia care: A single-center randomized controlled clinical trial
Remimazolam-based MAC for ERCP exhibited non-inferior efficacy compared to propofol-based MAC, while also resulting in fewer circulatory and respiratory adverse events during the procedures. Nevertheless, future studies with larger sample sizes are required to evaluate the utility of remimazolam in elderly patients.
Authors
- Ailin Luo (ORCID: https://orcid.org/0000-0001-8826-5588)
- Shiyong Li (ORCID: https://orcid.org/0000-0002-7052-5203)
- Hongbo Zheng (ORCID: https://orcid.org/0000-0003-3836-2472)
- Biyun Zhou
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e38349
- Citations
- 8
- Primary Topic
- Anesthesia and Sedative Agents
- Type
- article
- Field-Weighted Citation Impact
- 5.13
Funders
- CIEE Ping Foundation
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
- Natural Science Foundation of Hubei Province
- Tongji University
- Tongji Medical College, Huazhong University of Science and Technology